作者(順位) | 論文題目 | 發表期刊 |
---|---|---|
李健逢(4) | Uncovering the Inhibitory Molecular Mechanism of Pomegranate Peel to Urinary Bladder Urothelial Carcinoma Using Proteomics Techniques. | Life (Basel). 2022 Nov 9;12(11):1839. doi: 10.3390/life12111839. |
吳麗卿(9), 李健逢(11), 賴弘岳(C) | High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. | Pathol Res Pract. 2022 Nov;239:154158 |
李健逢(11) | Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. | Onco Targets Ther. 2022 Oct 11;15:1171-1181. |
李宛珊(8), 李健逢(C) | High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma. | Oncology. 2022;100(9):485-497. |
賴弘岳(2), 李宛珊(8), 李健逢(C) | Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma. | Onco Targets Ther. 2022 Jun 30;15:727-740. |
李健逢(C) | Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB. | Int J Mol Sci. 2022 May 3;23(9):5097. |
李健逢(2) | Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. | Cancers (Basel). 2022 Mar 31;14(7):1787. |
賴弘岳(1), 吳麗卿(5), 李健逢(C) | High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis. | Front Oncol. 2022 Mar 16;12:834249. |
李健逢(C) | Editorial: Molecular Mechanisms of Multiple Myeloma. | Front Oncol. 2022 Mar 10;12:870123. |
李健逢(C) | Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression. | Cells. 2022 Feb 11;11(4):638. |
李健逢(10) | Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. | Mod Pathol. 2022 Jul;35(7):911-921 |
李健逢(3) | Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers. | Clin Transl Med. 2022 Jan;12(1):e724. |
賴弘岳(1), 吳麗卿(2), 龔柏勳(3), 李健逢(C) | High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan. | Front Oncol. 2022 Jan 6;11:828314. |
李健逢(10) | Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions. | Am J Surg Pathol. 2022 Jul 1;46(7):942-955. |
李健逢(5) | Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions. | Pathol Res Pract. 2022 Jan;229:153700. |
賴弘岳(3) | Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma. | Clin Med Insights Oncol. 2022 Jul 22;16:11795549221113244. |
賴弘岳(3) | Formin-Like 2 Is a Potential Biomarker of Poor Prognosis in Nasopharyngeal Carcinoma. | Oncology. 2022;100(9):475-484. |
龔柏勳(1), 吳麗卿(5),李健逢(9) | Discrimination of Methicillin-resistant Staphylococcus aureus by MALDI-TOF Mass Spectrometry with Machine Learning Techniques in Patients with Staphylococcus aureus Bacteremia | Pathogens. 2022 May 16;11(5):586. |
廖乃鼎(1) | 以3D列印嬰兒足後跟模型於醫檢人員採血OSCE應用成效探討 | 台灣擬真醫學教育期刊/2022/第八卷第一期/15 |
2022年度研究發表
點擊數: 732